HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options    My Account    Help    
Now Available: Top 10 Stocks for 2010

These powerful long-term stocks for 2010 have just been announced. Our top picks for 2009 generated a +34.1% return. Don’t miss out. Learn more now.
Quote:
Login Free Membership
Search:

Top Zacks Features
Free Membership
Premium Home
Zacks Rank
Equity Research
My Portfolio
Stock Screener
Profit Tracks
Mutual Funds
Options
Zacks Video
RSS Feed
Profit from the Pros

Subscription Services
Top 10 Stocks
Product Guide
Zacks Premium
Zacks Elite
Method for Trading
Chart Patterns Trader
Double Your Money
ETF Trader
Growth Trader
Options Trader
Small Cap Trader
Strategic Investor
Surprise Trader
Value Trader
Special Reports
Research Wizard

Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive


AMSG: Amsurg Inc - Stock Quote Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Quote |  Detailed Quotes |  Real Time |  Options Chain |  Greeks Montage

AMSURG INC (NASD)
AMSG 20.50 N/A (N/A%) Vol.  0 N/A ET

Day Low - High N/A - N/A
52wk Low - High 12.23 - 23.61
Avg Volume 106,767
Industry MED-OUTP/HM CRE
Market Cap 625.38 M
Div - Yield 0.00 - 0.00
PE (forward) 11.15
PEG Ratio .99
Current Year Est. 1.83
EPS Last Year 1.69
Detailed Quote


Premium Research: Stock Analysis

Zacks Rank

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
Zacks Rank Definition Annualized Return
# 1Buy12%
# 2Strong Sell50.23%
# 3Hold14%
# 4Sell3.97%
# 5Hold1.85%
S&P50012.22%
Zacks Rank Education - Learn more about the Zacks Rank
Zacks Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank


upgraded 02/10/2010
Short-Term Rating 1-3 Months
PREMIUM
Zacks Recommendation

Zacks Recommendations are an excellent predictor of stock price movement over a 6+ month time frame. The recommendations come from the Zacks Equity Research group which combines the Zacks Rank with the insights from their team of over 50 equity analysts. The result is superior long term stock ratings.

The Zacks Recommendations are split into 3 groups: Outperform, Neutral and Underperform. When Zacks Premium members click on the recommendation it will launch them to the Zacks Equity Research report for the stock. More on these reports below.

Difference Between Zacks Rank and Zacks Recommendation
Zacks Equity Research Home
Zacks Premium - The only way to get access to Zacks Recommendations


Long-Term Rating 6+ Months
PREMIUM
Zacks Industry Rank

Which industries are set to outperform or underperform the market? You'll find the answer here. We have broken down all industries into over 200 classifications. Then ranked these industries using the most powerful indicator we know (the Zacks Rank). The higher the industry rank, the better the industry should perform in the future. Once you have found an attractive industry then check out the Rank in Industry to find the best stocks within the industry.

When Zacks Premium members click on the Zacks Industry Rank link they will see the full listing of industries and their current rankings.

About Zacks Industry Rank
Zacks Industry Rank - All current industry ranks.
Zacks Premium - The only way to get access to the Zacks Industry Rank

PREMIUM
Target Price

The Zacks Price Target provides you our expectation for a stocks share price in the next 6 months. These price targets are created by the Zacks Equity Research group to coincide with their recommendations that are also based on a 6 month time horizon.

Zacks Equity Research Home
Zacks Premium - The only way to get access to the Zacks Price Targets

PREMIUM
Equity Research Report

The Zacks Recommendations and Zacks Target Prices are just two of the valuable resources you'll find in the reports created by the Zacks Equity Research group. When Zacks Premium members click on this link they will taken to a page that gives them access to the Zacks Equity Research report for the stock.

Zacks Equity Research Home Zacks Premium - The only way to get access to Zacks Recommendations


Updated as of 12/01/2009
PREMIUM
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium

Premium Research: Industry Analysis

Top Peers Ticker Zacks Rank
AMSURG INC AMSG PREMIUM
AMEDISYS INC AMED PREMIUM
CHEMED CORP CHE PREMIUM
CONTINUCARE CRP CNU PREMIUM
See all MED-OUTP/HM CRE Peers

BROKERAGE RECOMMENDATIONS
Current ABR 2.84
ABR (Last Week) 2.84
# of Recs in ABR 19
Average Target Price 24.82
Industry Rank by ABR 128 out of 217
Rank in Industry 24 out of 30
More Brokerage Recommendations

Zacks Community PeopleAndPicks.com
Community Rating

PeopleAndPicks.com Community Stock Ratings

Rating Recommendation % of Stocks
5 stars Strong Buy 10%
4 stars Buy 20%
3 stars Hold 40%
2 stars Sell 20%
1 stars Strong Sell 10%
0 stars Not Rated  

We believe that a community of investors working together can create a superior stock rating system. Some call this "collective intelligence". Or simply...together we can beat the market!

A stock's Community Rating is calculated based on the aggregate input of the PeopleAndPicks Community. The proportion of buy to sell ratings, recency of analysis, and the average score of the users who rate it favorably all factor into a score of one to five stars.


How do you rate AMSG?
Buy
Sell
Find out what the Zacks Community
thinks of AMSG at PeopleAndPicks.com

NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.

 Interactive Java Charting
 Comparative Chart



 
ZACKS COMMENTARY FOR AMSG
Zacks Equity Research: Report for AMSG
Dec 01, 2009
Zacks Blog: AmSurg Beats Estimates Marginally
Oct 23, 2009
Zacks Blog: AmSurg Moves into Oversold Territory
Jul 10, 2009
Zacks Blog: Zacks Industry Rank Analysis Highlights: Healthsouth, Almost Family, AmSurg, DaVita, Emergency Medical Services, Genoptix and LHC Group.
May 14, 2009
Zacks Industry Rank Analysis: Good Numbers for Health Care Providers
May 13, 2009
Zacks Blog: Zacks Bull & Bear of the Day Highlights: AmSurg Corporation, Zimmer Holdings, Gannett, New York Times and PMI Group
Mar 17, 2009
Bull of the Day: AmSurg Corporation (AMSG)
Mar 17, 2009
Zacks Blog: AmSurg Upsurges to a Buy Rec
Mar 16, 2009
More Zacks Commentary
NEWS
AmSurg Corp. to Broadcast 2009 Fourth Quarter Conference Call Live on the Internet
Feb 03, 2010
SmarTrend's Candlestick Scanner Detects Bearish Harami Pattern for Amsurg (AMSG)
Jan 21, 2010
AmSurg Names John W. Popp, Jr., M.D. To Board of Directors
Nov 23, 2009
AmSurg (AMSG) Drops Over 3% With Bearish Technicals And Weak 2 STARs S&P Rating
Nov 13, 2009
AmSurg Reports 3Q Net Earnings from Continuing Operations
Oct 28, 2009
AmSurg Beats Estimates Marginally
Oct 24, 2009
Amsurg Guides Inline
Oct 22, 2009
AmSurg Announces Third-Quarter Net Earnings from Continuing Operations of $0.44 Per Diluted Share
Oct 22, 2009
More News
EARNINGS ESTIMATES
  This Quarter
12/2009
Next Quarter
03/2010
This Year
12/2009
Next Year
12/2010
Average Estimate 0.42 0.44 1.71 1.83
Number of Estimates 17 12 19 19
Low Estimates 0.41 0.42 1.70 1.76
High Estimate 0.43 0.46 1.72 1.87
Year Ago EPS 0.40 0.40 1.55 1.71
EPS Growth 4.56% 10.42% 10.08% 7.19%

More Estimates

COMPANY DESCRIPTION
AmSurg Corp. is in the business of developing, acquiring and operating practice-based ambulatory surgery centers, in partnerships with physician practice groups, throughout the United States. An AmSurg surgery center is typically located adjacent to or in the immediate vicinity of the specialty medical practice of a physician group partner's office. Each of the surgery centers provides a narrow range of high volume, lower-risk surgical procedures, generally in a single specialty.

Full Company Report
FINANCIALS
EPS TTM 1.69
Sales 600.66
Net Income 51.71
Price/Earnings 12.07
Price/Book 1.26
Price/Cash Flow 9.12
Price/Sales .96


More Financials

 
About Zacks | Advertise | Affiliate | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2010 Zacks Investment Research